Xavier Matias-Guiu Guia
Degree: PhD
973 705 340
fjmatiasguiu.lleida.ics(ELIMINAR)@gencat.cat
ResearcherID: http://www.researcherid.com/rid/C-3039-2009
Groups
Publications
-
Jung-Garcia Y; Maiques O; Monger J; Rodriguez-Hernandez I; Fanshawe B; Domart MC; Renshaw MJ; Marti RM; Matias-Guiu X; Collinson LM; Sanz-Moreno V; Carlton JG
LAP1 supports nuclear adaptability during constrained melanoma cell migration and invasion.
NATURE CELL BIOLOGY 25 108-119. .
-
Devis-Jauregui L; Vidal A; Plata-Peña L; Santacana M; García-Mulero S; Bonifaci N; Noguera-Delgado E; Ruiz N; Gil M; Dorca E; Llobet FJ; Coll-Iglesias L; Gassner K; Martinez-Iniesta M; Rodriguez-Barrueco R; Barahona M; Marti L; Viñals F; Ponce J; Sanz-Pamplona R; Piulats JM; Vivancos A; Matias-Guiu X; Villanueva A; Llobet-Navas D
Generation and Integrated Analysis of Advanced Patient-Derived Orthoxenograft Models (PDOX) for the Rational Assessment of Targeted Therapies in Endometrial Cancer.
Advanced Science 10 -. .
-
Lopez-Mejia IC; Pijuan J; Navaridas R; Santacana M; Gatius S; Velasco A; Castellà G; Panosa A; Cabiscol E; Pinyol M; Coll L; Bonifaci N; Peña LP; Vidal A; Villanueva A; Gari E; Llobet-Navàs D; Fajas L; Matias-Guiu X; Yeramian A
Oxidative stress-induced FAK activation contributes to uterine serous carcinoma aggressiveness.
MOLECULAR ONCOLOGY 17 98-118. .
-
Tarragona J; Martínez-Ciarpaglini C; Matias-Guiu X; Hardisson D
Docencia de pregrado en Anatomía Patológica: Resultados de la encuesta sobre la docencia de la asignatura de Anatomía Patológica en los estudios de pregrado de las facultades de medicina españolas.
Revista espanola de patologia : publicacion oficial de la Sociedad Espanola de Anatomia Patologica y de la Sociedad Espanola de Citologia 56 21-31. .
-
Carton-Garcia, F; Brotons, B; Anguita, E; Dopeso, H; Tarragona, J; Nieto, R; Garcia-Vidal, E; Macaya, I; Zagyva, Z; Dalmau, M; Sanchez-Martin, M; van Ijzendoorn SCD; Landolfi, S; Hernandez-Losa, J; Schwartz S Jr; Matias-Guiu, X; Ramón Y Cajal S; Martinez-Barriocanal, A; Arango, D
Myosin Vb as a tumor suppressor gene in intestinal cancer.
ONCOGENE 41 5279-5288. .
-
Vrede SW; Kasius J; Bulten J; Teerenstra S; Huvila J; Colas E; Gil-Moreno A; Boll D; Vos MC; van Altena AM; Asberger J; Sweegers S; van Weelden WJ; van der Putten LJM; Amant F; Visser NCM; Snijders MPLM; Küsters-Vandevelde HVN; Kruitwagen R; Matias-Guiu X; Weinberger V; Reijnen C; Pijnenborg JMA
Relevance of Molecular Profiling in Patients With Low-Grade Endometrial Cancer.
JAMA Network Open 5 -. .
-
Palomero J; Panisello C; Lozano-Rabella M; Tirtakasuma R; Díaz-Gómez J; Grases D; Pasamar H; Arregui L; Dorca Duch E; Guerra Fernández E; Vivancos A; de Andrea CE; Melero I; Ponce J; Vidal A; Piulats JM; Matias-Guiu X; Gros A
Biomarkers of tumor-reactive CD4(+) and CD8(+) TILs associate with improved prognosis in endometrial cancer.
Journal for ImmunoTherapy of Cancer 10 -. .
-
Sonzini, Giorgia; Granados-Aparici, Sofia; Sanegre, Sabina; Diaz-Lagares, Angel; Diaz-Martin, Juan; de Andrea, Carlos; Eritja, Nuria; Bao-Caamano, Aida; Costa-Fraga, Nicolas; Garcia-Ros, David; Salguero-Aranda, Carmen; Davidson, Ben; Lopez-Lopez, Rafael; Melero, Ignacio; Navarro, Samuel; Ramon Y Cajal, Santiago; de Alava, Enrique; Matias-Guiu, Xavier; Noguera, Rosa
Integrating digital pathology with transcriptomic and epigenomic tools for predicting metastatic uterine tumor aggressiveness.
Frontiers In Cell And Developmental Biology 10 1052098-1052098. .
-
Marin-Jimenez, Juan A.; Garcia-Mulero, Sandra; Matias-Guiu, Xavier; Piulats, Josep M.
Facts and hopes in immunotherapy of endometrial cancer.
CLINICAL CANCER RESEARCH 28 4849-4860. .
-
Matias-Guiu, X; Selinger, CI; Anderson, L; Buza, N; Ellenson, LH; Fadare, O; Ganesan, R; Ip PPC; Palacios, J; Parra-Herran, C; Raspollini, MR; Soslow, RA; Werner HMJ; Lax, SF; McCluggage, WG
Data Set for the Reporting of Endometrial Cancer: Recommendations From the International Collaboration on Cancer Reporting (ICCR).
INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY 41 90-118. .
-
Barcelo, C.; Siso, P.; de la Rosa, I.; Megino-Luque, C.; Navaridas, R.; Maiques, O.; Urdanibia, I.; Eritja, N.; Soria, X.; Potrony, M.; Calbet-Llopart, N.; Puig, S.; Matias-Guiu, X.; Marti, R. M.; Macia, A.
M-CSF as a therapeutic target in BRAF(V600E) melanoma resistant to BRAF inhibitors.
BRITISH JOURNAL OF CANCER 127 1142-1152. .
-
Egan D; Moran B; Wilkinson M; Pinyol M; Guerra E; Gatius S; Matias-Guiu X; Kolch W; le Roux CW; Brennan DJ
CRABP2 - A novel biomarker for high-risk endometrial cancer.
GYNECOLOGIC ONCOLOGY 167 314-322. .
Projects
- Homologous recombination deficiency in high-grade endometrial cancers. Biomarkers and impact of intratumor heterogeneity.
- EPH Receptor Signaling in Endometrial Cancer
- Ajuts per a la contractació de personal investigador novell (FI)
- Personalized Immunotherapy for Endometrial Cancer; Acronym: ExCITE (Endometrial Cancer Immunotherapy)
- "Multi-Omics data for Cancer Research and the Development of New Diagnostics and Therapies"
- EFFICACY: Nuevas estrategias para incrementar efectividad de los tratamientos con ABTL0812
- Incorporación de nuevas areas temáticas y nuevos grupos al consorcio CIBER
- Perfiles epigenéticos asociados a patrones de metastasis en cáncer de endometrio
- CONTRACTES D'INCORPORACIO DE CIENTIFICS I TECNOLEGS: INCORPORACIO D'UNA DOCTORA PER A L'ACCIO ANTITUMORAL DELS CANNABINOIDES EN EL CARCINOMA D'ENDOMETRI
- DISCOVERY, VALIDATION AND IMPLEMENTATION OF BIOMARKERS FOR PRECISION ONCOLOGY
- Desarrollo de nuevas aproximaciones en el manejo individualizado de pacientes con cancer ginecológico (PREDICTGYN)
- VALIDACION DE ANEXINA 2 COMO PREDICTOR DE RECIDIVA EN EL CANCER DE ENDOMETRIO. DISEÑO DE NUEVAS ESTRATEGIAS TERAPEUTICAS. ANXARECU
